Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2014 | 1 |
2018 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
N Engl J Med. 2018 Sep 20;379(12):1107-1117. doi: 10.1056/NEJMoa1808721. Epub 2018 Aug 26.
N Engl J Med. 2018.
PMID: 30145941
Free article.
Clinical Trial.
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Dwyer JP, Corbalan R, Hamm C, Kaplan L, Nicolau JC, Ophuis TO, Ray KK, Ruda M, Spinar J, Patel T, Miao W, Perdomo C, Francis B, Dhadda S, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD; CAMELLIA-TIMI 61 Steering Committee Investigators.
Bohula EA, et al.
Lancet. 2018 Nov 24;392(10161):2269-2279. doi: 10.1016/S0140-6736(18)32328-6. Epub 2018 Oct 4.
Lancet. 2018.
PMID: 30293771
Free article.
Clinical Trial.
Item in Clipboard
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US.
Cannon CP, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Gao Q, Palagashvilli T, Alam S, Mues KE, Bhatt DL, Kosiborod MN; GOULD Investigators.
Cannon CP, et al.
JAMA Cardiol. 2021 Jun 16;6(9):1-9. doi: 10.1001/jamacardio.2021.1810. Online ahead of print.
JAMA Cardiol. 2021.
PMID: 34132735
Free PMC article.
Item in Clipboard
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R; LAPLACE-2 Investigators.
Robinson JG, et al.
JAMA. 2014 May 14;311(18):1870-82. doi: 10.1001/jama.2014.4030.
JAMA. 2014.
PMID: 24825642
Clinical Trial.
Item in Clipboard
Cerebral infarct and adult respiratory distress syndrome in a patient with postanginal sepsis.
Marangos MN, Fuchs-Ertman DA, Kourea HP, Meurer KJ, Lerwick PA, Zimmerman SH, Valenti AJ.
Marangos MN, et al. Among authors: fuchs ertman da.
Clin Microbiol Infect. 2000 Jun;6(6):337-9. doi: 10.1046/j.1469-0691.2000.00090.x.
Clin Microbiol Infect. 2000.
PMID: 11168147
Free article.
No abstract available.
Item in Clipboard
Cite
Cite